To FDA on labeling of plant-based milk alternatives and voluntary nutrient statements

GFI urges FDA to treat plant-based milks fairly and avoid any labeling scheme that would unfairly burden one class of products in the marketplace.

Shutterstock 417839803

Comment letters

GFI submits public comments to policymakers in order to advance alternative proteins strategically and with integrity.